Factor H Antibody (Polyclonal)

A goat antiserum raised against human Factor H.


Product Specifications

Citations32
Clonality

Polyclonal

Immnogen

Highly purified human Factor H

Applications

See citations and technical data sheet for application info.

Concentration> 40 mg/mL
ConjugateUnconjugated
Cross Reactivity

Human, Baboon, Horse, Dog, Cat, Rabbit, Hamster, Mouse, Rat, Guinea Pig

Ordering Information

For Research Use Only in the United States. Not for use in diagnostic procedures.
Catalog NumberA312
Catalog Number (CE)N/A
Size2.0 mL
Price (USD)$195.00
Price (EURO)170,00 €

Contact us

US Phone+1 (858) 552 1100
EU Phone+353 (91) 412 474
US Emailcontact-us@quidelortho.com
EU Emailcontact-emea@quidelortho.com

Specifications

Description

A goat antiserum raised against human Factor H.

Size

2.0 mL

Concentration> 40 mg/mL
ApplicationsSee citations and technical data sheet for application info.
FormLiquid. Whole Antiserum. ≤ 0.1% Sodium Azide
ClonalityPolyclonal
Immunogen

Highly purified human Factor H

ConjugateUnconjugated
Cross ReactivityHuman, Baboon, Horse, Dog, Cat, Rabbit, Hamster, Mouse, Rat, Guinea Pig
Isotype

Goat IgG

Purity

N/A

SourceGoat
Specificity

The Anti-human Factor H polyclonal antisera was tested against normal human serum/plasma by immunodiffusion, one-dimensional immunoelectrophoresis, and rocket immunoelectrophoresis. The antisera was determined to be monospecific for Factor H at varying concentrations.

Storage

Short term (30 days) 4˚C. Long term at or below –20˚C.

Background

Factor H is a single-chain glycoprotein with a molecular weight of approximately 150 KD. The concentration of this protein in normal human plasma/serum is approximately 500 µg/mL. Factor H can regulate the complement system on both the cellular surface and in fluid phase, and plays roles in both the alternative and classical pathways of activation. Factor H regulates formation and function of C3 convertase enzyme in the alternative pathway. It binds to C3b and inhibits C3 convertase formation, dissociates assembled C3 convertase, accelerates Factor I mediated cleavage of C3b to C3bi, and hinders C5 binding to the C3b subcomponent of both the alternative and classical pathways. Factor H also regulates the spontaneous fluid-phase activation of the alternative complement pathway by C3b-like forms of C3 that continuously arise in plasma and serum. Therefore, when concentrations of Factor H fall below normal levels, rapid fluid-phase activation occurs which causes consumption of complement components both in vivo and in vitro.

Citations

TitleYearApplicationsSample SpeciesSampleSample Details

Mechanism of Borrelia immune evasion by FhbA-related proteins

2022WBBacteria

Borrelia hermsii

N/A

Systemic complement levels in patients with age-related macular degeneration carrying rare or low frequency variants in the CFH gene.

2021ELISAHuman

Plasma

N/A

Clinicopathologic Implications of Complement Genetic Variants in Kidney Transplantation.

2021ELISAHuman

Protein

Factor H WT and Variants

Defining the Glycosaminoglycan Interactions of Complement Factor H-Related Protein 5

2021ELISAHuman

Purified protein

N/A

Common haplotypes at the CFH locus and low-frequency variants in CFHR2 and CFHR5 associate with systemic FHR concentrations and age-related macular degeneration.

2021ELISAHuman

Serum

Age-Related Macular Degeneration

Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis.

2020ELISA, IF, WBMouse

Kidney Tissue

N/A

Circulating FH Protects Kidneys From Tubular Injury During Systemic Hemolysis.

2020ELISA, IF, WBMouse

Plasma

N/A

Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.

2019ELISAHuman

Plasma

N/A

Novel Assays to Distinguish Between Properdin-Dependent and Properdin-Independent C3 Nephritic Factors Provide Insight Into Properdin-Inhibiting Therapy.

2019ELISAHuman

Serum

N/A

Anti-Factor H Antibody Reactivity in Young Adults Vaccinated With a Meningococcal Serogroup B Vaccine Containing Factor H Binding Protein.

2019Hemolytic AssayHuman

Serum

N/A

ApoE Attenuates Unresolvable Inflammation by Complex Formation With Activated C1q.

2019IFHuman

Choroid plexus Tissue

N/A

Antigenic Variation in Streptococcus pneumoniae PspC Promotes Immune Escape in the Presence of Variant-Specific Immunity.

2018FCBacteria

Streptococcus pneumoniae

N/A

Recruitment of Factor H to the Streptococcus suis Cell Surface is Multifactorial.

2016ELISABacteria

Streptococcus suis

N/A

Mapping rare, deleterious mutations in Factor H: Association with early onset, drusen burden, and lower antigenic levels in familial AMD

2016ELISAHuman

Purified Protein

N/A

Mapping rare, deleterious mutations in Factor H: Association with early onset, drusen burden, and lower antigenic levels in familial AMD

2016ELISAHuman

Serum

N/A

Annexin A2 Enhances Complement Activation by Inhibiting Factor H

2016ELISA, WBMouse

Kidney Tissue

N/A

Annexin A2 Enhances Complement Activation by Inhibiting Factor H

2016ELISA, WBMouse

Plasma

N/A

Regulation of C3 Activation by the Alternative Complement Pathway in the Mouse Retina

2016WBMouse

Plasma

N/A

Complement Factor H Expressed by Retinal Pigment Epithelium Cells Can Suppress Neovascularization of Human Umbilical Vein Endothelial Cells: An in vitro Study

2015IF, WBHuman

ARPE-19 cells

N/A

Activation of complement system in kidney after ketoprofen-induced kidney injury in sheep

2015IHCHuman

Kidney Tissue

N/A

The C-type lectin of the aggrecan G3 domain activates complement

2013ELISAHuman

Purified protein

N/A

Cyclosporine induces endothelial cell release of complement-activating microparticles

2013FCHuman

Endothelial Cells

Microparticles incubation

Reduction of complement factor H binding to CLL cells improves the induction of rituximab-mediated complement-dependent cytotoxicity

2013WBCell Culture

CLL Cells

N/A

Expression of complement components, receptors and regulators by human dendritic cells

2011WBHuman

Monocyte Derived Dendritic Cell

N/A

Binding of factor H to tubular epithelial cells limits interstitial complement activation in ischemic injury

2011WBMouse

Serum

N/A

Attenuation of renal ischemia and reperfusion injury by human adrenomedullin and its binding protein

2010WBHuman

Plasma

N/A

Resuscitation of uncontrolled traumatic hemorrhage induced by severe liver injury: the use of human adrenomedullin and adrenomedullin binding protein-1

2010WBHuman

Plasma

N/A

Short leucine-rich glycoproteins of the extracellular matrix display diverse patterns of complement interaction and activation

2009ELISAN/A

Purified protein

SLRP

Factor H facilitates the clearance of GBM bound iC3b by controlling C3 activation in fluid phase.

2009WBMouse

Serum

N/A

Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding protein

2008FC, IFHuman

Plasma

Aspergillus incubated

Pro-inflammatory cytokines from Kupffer cells downregulate hepatocyte expression of adrenomedullin binding protein-1

2007WBRat

Hepatocytes

N/A

Pro-inflammatory cytokines from Kupffer cells downregulate hepatocyte expression of adrenomedullin binding protein-1

2007WBRat

Kupffer cells

N/A